Does MYCOPHENOLATE MOFETIL Cause Interstitial lung disease? 702 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 702 reports of Interstitial lung disease have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 0.9% of all adverse event reports for MYCOPHENOLATE MOFETIL.
702
Reports of Interstitial lung disease with MYCOPHENOLATE MOFETIL
0.9%
of all MYCOPHENOLATE MOFETIL reports
123
Deaths
305
Hospitalizations
How Dangerous Is Interstitial lung disease From MYCOPHENOLATE MOFETIL?
Of the 702 reports, 123 (17.5%) resulted in death, 305 (43.4%) required hospitalization, and 91 (13.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for MYCOPHENOLATE MOFETIL.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Interstitial lung disease Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE